Brian T Palumbo1, Eric Henderson2, Justin Rizer3, Douglas G Letson3, David Cheong3. 1. Florida Orthopaedic Institute, 13020 Telecom Parkway N, Tampa, FL, United States. 2. Orthopaedic Oncology, Dartmouth-Hitchcock Medical Center, The Geisel School of Medicine at Dartmouth, Lebanon, NH, United States. 3. Moffitt Cancer Center, Tampa, FL, United States.
Abstract
OBJECTIVES: As adjuvant treatments for musculoskeletal malignancies improve expectations of preserved function increase. We questioned whether computer navigation for distal femoral reconstruction would improve outcomes. METHODS: Twenty oncology patients were reviewed after distal femoral reconstruction using navigation. Outcomes included local recurrence, implant revision, patient function, patellofemoral complications and leg-length inequality. RESULTS: Implant survivorship was 85% at 26 months. There were no local recurrences and 3 failures for aseptic loosening. Good functional outcomes were observed in remaining cases. CONCLUSION: Computer navigation for distal femoral reconstruction resulted in acceptable functional outcomes and implant survivorship. Reduced local recurrence were observed at intermediate follow-up. Level of Evidence: Level IV.
OBJECTIVES: As adjuvant treatments for musculoskeletal malignancies improve expectations of preserved function increase. We questioned whether computer navigation for distal femoral reconstruction would improve outcomes. METHODS: Twenty oncology patients were reviewed after distal femoral reconstruction using navigation. Outcomes included local recurrence, implant revision, patient function, patellofemoral complications and leg-length inequality. RESULTS: Implant survivorship was 85% at 26 months. There were no local recurrences and 3 failures for aseptic loosening. Good functional outcomes were observed in remaining cases. CONCLUSION: Computer navigation for distal femoral reconstruction resulted in acceptable functional outcomes and implant survivorship. Reduced local recurrence were observed at intermediate follow-up. Level of Evidence: Level IV.
Authors: Eduardo N Novais; Bahtiyar Demiralp; Joseph Alderete; Melissa C Larson; Peter S Rose; Franklin H Sim Journal: Clin Orthop Relat Res Date: 2010-11 Impact factor: 4.176
Authors: Vignesh K Alamanda; Samuel N Crosby; Kristin R Archer; Yanna Song; Herbert S Schwartz; Ginger E Holt Journal: Acta Oncol Date: 2012-08-09 Impact factor: 4.089
Authors: Eric R Henderson; John S Groundland; Elisa Pala; Jeremy A Dennis; Rebecca Wooten; David Cheong; Reinhard Windhager; Rainer I Kotz; Mario Mercuri; Philipp T Funovics; Francis J Hornicek; H Thomas Temple; Pietro Ruggieri; G Douglas Letson Journal: J Bone Joint Surg Am Date: 2011-03-02 Impact factor: 5.284
Authors: Aaron Sabolch; Mary Feng; Kent Griffith; Callie Rzasa; Laura Gadzala; Felix Feng; Janet Sybil Biermann; Rashmi Chugh; Michael Ray; Edgar Ben-Josef Journal: Am J Clin Oncol Date: 2012-04 Impact factor: 2.339
Authors: Sven Hoppe; Jens D Mainzer; Lars Frauchiger; Peter M Ballmer; Rolf Hess; Matthias A Zumstein Journal: Acta Orthop Date: 2012-11-11 Impact factor: 3.717